GLP1R and obesity due to melanocortin 4 receptor deficiency: Additionally, treatment with these traditional anti-obesity drugs may be attempted in patients with eating disorders, as topiramate, lisdexamfetamine (the only FDA-approved medication for binge-eating disorder), and, more recently, GLP-1 agonists have been shown to improve binge-eating episodes (12).